(Q37816933)

23 August 2017

1 reference

title

Insights into the cellular origin and etiology of the infant pro-B acute lymphoblastic leukemia with MLL-AF4 rearrangement (English)

1 reference

23 August 2017

1 reference

lymphoblastic leukemia

1 reference

4

0 references

Purificación Catalina

object named as

P Catalina

3

0 references

Pablo Menendez

object named as

P Menendez

5

0 references

author name string

C Bueno

1

1 reference

23 August 2017

R Montes

2

1 reference

23 August 2017

language of work or name

1 reference

7 December 2010

1 reference

23 August 2017

1 reference

23 August 2017

volume

25

1 reference

23 August 2017

issue

3

1 reference

23 August 2017

page(s)

400-410

1 reference

https://scigraph.springernature.com/pub.10.1038/leu.2010.284

23 August 2017

exact match

0 references

cites work

The amino terminus targets the mixed lineage leukemia (MLL) protein to the nucleolus, nuclear matrix and mitotic chromosomal scaffolds

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

MLL chimeric protein activation renders cells vulnerable to chromosomal damage: an explanation for the very short latency of infant leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Molecular pathogenesis of MLL-associated leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

MLL translocations, histone modifications and leukaemia stem-cell development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Acute lymphoblastic leukemia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

FLT3 mutations in the activation loop of tyrosine kinase domain are frequently found in infant ALL with MLL rearrangements and pediatric ALL with hyperdiploidy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

In utero rearrangements in the trithorax-related oncogene in infant leukaemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Maternal exposure to potential inhibitors of DNA topoisomerase II and infant leukemia (United States): a report from the Children's Cancer Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Dietary flavonoids induce MLL translocations in primary human CD34+ cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Etoposide-initiated MLL rearrangements detected at high frequency in human primitive hematopoietic stem cells with in vitro and in vivo long-term repopulating potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

MLL rearrangements are induced by low doses of etoposide in human fetal hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Analysis of foetal expression sites of human type II DNA topoisomerase alpha and beta mRNAs by in situ hybridisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Maternal diet and infant leukemia: the DNA topoisomerase II inhibitor hypothesis: a report from the children's oncology group

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Scientific and clinical opportunities for modeling blood disorders with embryonic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Human embryonic stem cells: potential tool for achieving immunotolerance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Pharmacokinetics and pharmacodynamics of oral etoposide in children with relapsed or refractory acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Conventional and molecular cytogenetic diagnostic methods in stem cell research: a concise review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Electron microscopy reveals the presence of viruses in mouse embryonic fibroblasts but neither in human embryonic fibroblasts nor in human mesenchymal cells used for hESC maintenance: toward an implementation of microbiological quality assurance pro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Whole-blastocyst culture followed by laser drilling technology enhances the efficiency of inner cell mass isolation and embryonic stem cell derivation from good- and poor-quality mouse embryos: new insights for derivation of human embryonic stem cel

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Mesenchymal stem cells facilitate the derivation of human embryonic stem cells from cryopreserved poor-quality embryos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Human embryonic stem cells: A journey beyond cell replacement therapies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Retroviral transduction of hematopoietic cells differentiated from human embryonic stem cell-derived CD45(neg)PFV hemogenic precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Infection, immune responses and the aetiology of childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Cancer incidence in atomic bomb survivors. Part III. Leukemia, lymphoma and multiple myeloma, 1950-1987.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Risk of childhood cancer from fetal irradiation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

An infectious aetiology for childhood acute leukaemia: a review of the evidence

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Aetiology of acute leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Leukemia in twins: lessons in natural history

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Origins of chromosome translocations in childhood leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Developmental impact of leukemic fusion genes on stem cell fate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Correlation of surface antigens and cell type in cloned cell lines from the rat central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Expression of the human homologue of rat NG2 in adult acute lymphoblastic leukemia: close association with MLL rearrangement and a CD10(-)/CD24(-)/CD65s(+)/CD15(+) B-cell phenotype.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Detection of acute leukemia cells with mixed lineage leukemia (MLL) gene rearrangements by flow cytometry using monoclonal antibody 7.1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal/reactive and myelodysplastic syndrome precursors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Gene expression profiling-based dissection of MLL translocated and MLL germline acute lymphoblastic leukemia in infants

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Secondary malignant neoplasms of the bladder after cyclophosphamide treatment for childhood acute lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Mesenchymal stem cells remain of host origin even a long time after allogeneic peripheral blood stem cell or bone marrow transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Standardized MRD quantification in European ALL trials: proceedings of the Second International Symposium on MRD assessment in Kiel, Germany, 18-20 September 2008.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Hemangioblasts representing a functional endothelio-hematopoietic entity in ontogeny, postnatal life, and CML neovasculogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Chromosomal aberrations in bone marrow mesenchymal stroma cells from patients with myelodysplastic syndrome and acute myeloblastic leukemia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Leukemia-associated genetic aberrations in mesenchymal stem cells of children with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

The versatile mixed lineage leukaemia gene MLL and its many associations in leukaemogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

A murine Mll-AF4 knock-in model results in lymphoid and myeloid deregulation and hematologic malignancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Combined effects of the two reciprocal t(4;11) fusion proteins MLL.AF4 and AF4.MLL confer resistance to apoptosis, cell cycling capacity and growth transformation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

The AF4.MLL fusion protein is capable of inducing ALL in mice without requirement of MLL.AF4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Embryonic stem cell lines derived from human blastocysts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

Studies of FLT3 mutations in paired presentation and relapse samples from patients with acute myeloid leukemia: implications for the role of FLT3 mutations in leukemogenesis, minimal residual disease detection, and possible therapy with FLT3 inhibit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

A conditional model of MLL-AF4 B-cell tumourigenesis using invertor technology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

DNA copy-number abnormalities do not occur in infant ALL with t(4;11)/MLL-AF4

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

The translocations, t(11;19)(q23;p13.1) and t(11;19)(q23;p13.3): a cytogenetic and clinical profile of 53 patients. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Etoposide induces chimeric Mll gene fusions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Secondary leukemias induced by topoisomerase-targeted drugs

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

International workshop on the relationship of prior therapy to balanced chromosome aberrations in therapy-related myelodysplastic syndromes and acute leukemia: overview report

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Infant leukemia, topoisomerase II inhibitors, and the MLL gene

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Validation of NG2 antigen in identifying BP-ALL patients with MLL rearrangements using qualitative and quantitative flow cytometry: a prospective study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

NG2 expression in MLL rearranged acute myeloid leukaemia is restricted to monoblastic cases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Extensive characterization of the immunophenotype and pattern of cytokine production by distinct subpopulations of normal human peripheral blood MHC II+/lineage- cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

NG2 antigen is expressed in CD34+ HPCs and plasmacytoid dendritic cell precursors: is NG2 expression in leukemia dependent on the target cell where leukemogenesis is triggered?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Influence of the different CD34+ and CD34- cell subsets infused on clinical outcome after non-myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen-identical sibling donors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Mesenchymal stem cells are of recipient origin in pediatric transplantations using umbilical cord blood, peripheral blood, or bone marrow

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Bone marrow-derived mesenchymal stem cells remain host-derived despite successful hematopoietic engraftment after allogeneic transplantation in patients with lysosomal and peroxisomal storage diseases

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Human mesenchymal stem cells are not of donor origin in patients with severe aplastic anemia who underwent sex-mismatched allogeneic bone marrow transplant

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Evidence from a leukaemia model for maintenance of vascular endothelium by bone-marrow-derived endothelial cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Lymphoma-specific genetic aberrations in microvascular endothelial cells in B-cell lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Bone marrow mesenchymal stem cells are abnormal in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q- syndrome

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Where do the leukaemia relapses come from?

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Interleukin-4 variant (BAY 36-1677) selectively induces apoptosis in acute lymphoblastic leukemia cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2010.284

7 January 2021

Identifiers

DOI

10.1038/LEU.2010.284

1 reference

23 August 2017

1 reference